ABS Direct Equity Fund’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-15,000
Closed -$360K 35
2025
Q2
$360K Sell
15,000
-130,000
-90% -$3.01M 0.57% 32
2025
Q1
$3.32M Sell
145,000
-15,000
-9% -$362K 4.44% 4
2024
Q4
$4.05M Buy
160,000
+35,100
+28% +$889K 4.7% 4
2024
Q3
$3.11M Buy
124,900
+4,668
+4% +$138K 3.47% 9
2024
Q2
$3.56M Sell
120,232
-1,028
-0.8% -$28.5K 4% 7
2024
Q1
$3.66M Buy
+121,260
New +$3.36M 3.58% 8

Other funds holding RTO

ABS Direct Equity Fund's RTO Position: Q3 2025 in Review

ABS Direct Equity Fund sold out of Rentokil (RTO) in Q3 2025, closing a stake of 15,000 shares — an estimated $360K sold.

ABS Direct Equity Fund first reported a position in RTO in Q1 2024 and held it in 6 quarters. The position peaked at $4.05M in Q4 2024. 213 funds tracked by Wall St. Rank hold RTO as of Q3 2025.

  • ABS Direct Equity Fund reported no remaining Rentokil position as of Q3 2025 after selling out during the quarter.
  • ABS Direct Equity Fund sold 15,000 Rentokil shares in Q3 2025, an estimated $360K.
  • ABS Direct Equity Fund first reported a position in Rentokil in Q1 2024 and held it in 6 quarters.
  • ABS Direct Equity Fund's Rentokil position peaked at $4.05M in Q4 2024.
  • 213 funds tracked by Wall St. Rank held Rentokil as of Q3 2025.

Based on ABS Direct Equity Fund's 13F filing for Q3 2025, filed 9 Oct 2025.